Amir Danino
Co-founder & CEO
Claimed by owner Innoventric
Former names:
Transcatheter Solution for Tricuspid Regurgitation
Innoventric
About
Innoventric is a structural heart medical device company engaged primarily in the development of percutaneous solutions for tricuspid regurgitation and right heart disease.
The company has developed an easily deployable percutaneous functional tricuspid valve replacement that utilizes cross-caval anchoring and an innovative multi-valve design for long-lasting blood flow regulation.
Innoventric is dedicated to the development of simple yet sophisticated transcatheter solutions to significantly improve the quality of life and life span of patients with structural heart disease.
The company has developed an easily deployable percutaneous functional tricuspid valve replacement that utilizes cross-caval anchoring and an innovative multi-valve design for long-lasting blood flow regulation.
Innoventric is dedicated to the development of simple yet sophisticated transcatheter solutions to significantly improve the quality of life and life span of patients with structural heart disease.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
Trillium
Geographic markets
Europe, United States
The Team
(3)
AD
DP
David Planer
Co-founder & CMO
RB
Rafi Benary
Co-founder & Head of BD
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Seed
Undisclosed
Aug 2017
Undisclosed
A Round
$11M
Nov 2021
1 Investors
$11M
Non-Equity Funding
Grant
$3M
Nov 2021
1 Grantors
$3M
Media gallery
(0)Locations
Israel
Golda Me'ir Street 3, Ness Ziona, Israel
Locations
Israel
Golda Me'ir Street 3, Ness Ziona, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,